Oruka Therapeutics Stock (NASDAQ:ORKA)
Previous Close
$33.69
52W Range
$5.49 - $36.53
50D Avg
$32.54
200D Avg
$22.83
Market Cap
$1.29B
Avg Vol (3M)
$513.98K
Beta
-0.44
Div Yield
$19.36
ORKA Company Profile
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.